Healthcare Global Enterprises Limited

NSE: HCG · Healthcare

Healthcare Global Enterprises Limited Share Price & Analysis

661.25 +1.15%Updated 21 Jul 2026, 05:01 pm IST
LTP
661.25
+1.15%
Open
High
667.25
Low
650.7
Close
₹661.25
52W High
₹800
52W Low
₹513
Volume
498K
Lot Size
1
Sector
Healthcare
Market Cap
₹10K Cr
Face Value
₹10
Mid Cap

Price Chart

Fundamentals

P/E
341
Sector P/E
54.4
P/B
9.62
EPS
₹0.97
ROE
2.55%
ROCE
8.31%
D/E Ratio
1.23
Div Yield
0%
Book Value
₹89.2

Concerns

  • Premium to sector peers (P/E 341x vs industry 54.4x)
  • High premium to book value (P/B 9.6x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

HCG · as of Mar 2026

Promoters71.22%
FII2.44%0.33
DII12.48%0.46
Public13.86%0.79
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters71.29%71.28%71.26%71.23%71.22%71.22%
FII6.37%6.74%3.95%4.30%2.77%2.44%
DII8.46%8.52%10.89%11.64%12.94%12.48%
Public13.89%13.45%13.90%12.84%13.07%13.86%

Corporate Events

Rights 1:17 @ Premium Rs 502/-

Rights1 Mar 2026

Latest News

All news →

P&G Hygiene & Health Care sees management change

*P&G Hygiene & Health Care reports change in senior management.* The company disclosed a management reshuffle via an NSE filing, without specifying roles or individuals. Such changes may influence strategic direction over time but no immediate financial impact is expected. Investor sentiment likely to remain stable. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #ManagementChange

NSE Filing1 Jul
High Impact

Aster DM Healthcare sets record date post-NCLT approval

*Aster DM Healthcare sets record date post-NCLT approval*. The company has noted the NCLT order and fixed a record date for the amalgamation scheme. The move paves the way for the proposed corporate restructuring. Shareholders will be eligible for benefits based on the record date. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Amalgamation

NSE Filing25 Jun
High Impact

Aster DM Healthcare to acquire healthcare assets

*Aster DM Healthcare to acquire healthcare assets.* The company announced a strategic acquisition to expand its medical network. Deal size and specific assets remain undisclosed. This move aims to strengthen its presence in key markets. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Acquisition

NSE Filing18 Jun
High Impact

P&G Hygiene and Health Care announces management change

*P&G Hygiene and Health Care announces management change* — The company has disclosed a change in its senior management personnel to the stock exchange. No further details on the individuals involved or the nature of the change were provided. Such corporate updates typically have limited market impact unless tied to strategic shifts. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #ManagementChange

NSE Filing12 Jun
High Impact

Aster DM Healthcare completes merger with Quality Care India

*Aster DM Healthcare completes merger with Quality Care India* Aster DM Healthcare announced the successful completion of its merger with Quality Care India Limited, effective July 02, 2026. The consolidation aims to strengthen Aster’s hospital network and enhance operational scale. This integration is expected to improve cost efficiencies and expand patient reach across key markets. 📊 *STOCKS:* ASTERDM | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Merger

NSE Filing2 Jul
Medium Impact

P&G to hold 62nd AGM on September 2, 2026

*P&G to hold 62nd AGM on September 2, 2026.* The company has informed the exchange about the upcoming annual general meeting. No financial updates or strategic announcements were disclosed. This is a routine corporate calendar update. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #AGM

NSE Filing10 Jul
Low Impact

GPT Healthcare shares may react to newspaper publication

*GPT Healthcare shares may react to newspaper publication* as the company filed a copy of its newspaper publication with the NSE. This appears to be a routine disclosure with no **₹ value** or financial impact indicated. No specific event like dividend, merger, or result is mentioned. Traders should monitor for further clarity. 📊 *STOCKS:* GPTHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling

NSE Filing10 Jul
Low Impact

P&G Hygiene discloses insider trading regulation filing

*P&G Hygiene discloses insider trading regulation filing.* The company filed disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. This is a routine regulatory requirement and does not indicate any adverse action. No financial impact is expected from this disclosure. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #InsiderTrading

NSE Filing19 Jun
Low Impact

P&G India to present investor update

*P&G India to present investor update.* The company informed the exchange about an upcoming investor presentation. This event aims to provide updates on business strategy and performance. No financial figures or major announcements were disclosed. 📊 *STOCKS:* PGHH | 🏢 *SECTOR:* FMCG | #LOWIMPACT #investor-presentation

NSE Filing16 Jun
Low Impact

Healthcare Global Enterprises publishes newspaper notice

*Healthcare Global Enterprises publishes newspaper notice.* This is a routine corporate filing submitted to the NSE. No financial or operational details were disclosed. Such notices are typically procedural. 📊 *STOCKS:* HGEL | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #corporate

NSE Filing9 Jun
Low Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
₹652.33 Cr
▲3.0%
₹633.07 Cr
▼2.1%
₹646.85 Cr
▲5.5%
₹613.16 Cr
▲4.8%
₹585.16 Cr
▲4.8%
₹558.57 Cr
▲0.9%
₹553.54 Cr
▲5.3%
₹525.58 Cr
Op. Profit
₹125.08 Cr
▲14.2%
₹109.56 Cr
▼11.2%
₹123.31 Cr
▲14.4%
₹107.79 Cr
▲2.0%
₹105.63 Cr
▲19.5%
₹88.38 Cr
▼13.6%
₹102.24 Cr
▲12.5%
₹90.9 Cr
OPM
19.2%
▲10.7%
17.3%
▼9.2%
19.1%
▲8.4%
17.6%
▼2.6%
18.1%
▲14.1%
15.8%
▼14.3%
18.5%
▲6.8%
17.3%
Net Profit
₹4.04 Cr
▲151.1%
₹-7.9 Cr
▼138.2%
₹20.66 Cr
▲245.5%
₹5.98 Cr
▼11.7%
₹6.77 Cr
▼12.6%
₹7.75 Cr
▼62.5%
₹20.68 Cr
▲51.7%
₹13.63 Cr
EPS (₹)
0.15
▲123.8%
-0.63
▼157.8%
1.09
▲240.6%
0.32
▼36.0%
0.5
▲6.4%
0.47
▼61.5%
1.22
▲48.8%
0.82

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹2.5K Cr
▲14.7%
₹2.2K Cr
▲16.2%
₹1.9K Cr
▲12.8%
₹1.7K Cr
▲21.2%
₹1.4K Cr
▲38.3%
₹1.0K Cr
▼7.6%
₹1.1K Cr
▲11.9%
₹976 Cr
▲17.7%
₹829 Cr
▲18.4%
₹700 Cr
Expenses
₹2.1K Cr
▲13.4%
₹1.8K Cr
▲16.1%
₹1.6K Cr
▲13.4%
₹1.4K Cr
▲20.1%
₹1.2K Cr
▲30.9%
₹887 Cr
▼5.2%
₹936 Cr
▲8.3%
₹864 Cr
▲21.2%
₹713 Cr
▲19.8%
₹595 Cr
Op. Profit
₹466 Cr
▲21.4%
₹384 Cr
▲17.4%
₹327 Cr
▲10.1%
₹297 Cr
▲26.9%
₹234 Cr
▲91.8%
₹122 Cr
▼22.3%
₹157 Cr
▲40.2%
₹112 Cr
▼3.4%
₹116 Cr
▲10.5%
₹105 Cr
OPM
18.0%
▲5.9%
17.0%
▲0.0%
17.0%
▼5.6%
18.0%
▲5.9%
17.0%
▲41.7%
12.0%
▼14.3%
14.0%
▲27.3%
11.0%
▼21.4%
14.0%
▼6.7%
15.0%
Other Income
₹-18 Cr
▼146.2%
₹39 Cr
▲62.5%
₹24 Cr
▲60.0%
₹15 Cr
▼86.4%
₹110 Cr
▲252.8%
₹-72 Cr
▼820.0%
₹10 Cr
▲0.0%
₹10 Cr
▼60.0%
₹25 Cr
▲150.0%
₹10 Cr
Interest
₹177 Cr
▲14.2%
₹155 Cr
▲42.2%
₹109 Cr
▲4.8%
₹104 Cr
▲6.1%
₹98 Cr
▼17.6%
₹119 Cr
▼13.8%
₹138 Cr
▲97.1%
₹70 Cr
▲66.7%
₹42 Cr
▲82.6%
₹23 Cr
Depreciation
₹244 Cr
▲15.6%
₹211 Cr
▲21.3%
₹174 Cr
▲6.7%
₹163 Cr
▲3.2%
₹158 Cr
▼0.6%
₹159 Cr
▲7.4%
₹148 Cr
▲74.1%
₹85 Cr
▲19.7%
₹71 Cr
▲24.6%
₹57 Cr
PBT
₹27 Cr
▼52.6%
₹57 Cr
▼16.2%
₹68 Cr
▲51.1%
₹45 Cr
▼48.9%
₹88 Cr
▲138.4%
₹-229 Cr
▼92.4%
₹-119 Cr
▼260.6%
₹-33 Cr
▼222.2%
₹27 Cr
▼22.9%
₹35 Cr
Tax %
15.0%
▲7.1%
14.0%
▼64.1%
39.0%
▼36.1%
61.0%
▲8.9%
56.0%
▲1966.7%
-3.0%
▼160.0%
5.0%
▲171.4%
-7.0%
▼118.4%
38.0%
▲11.8%
34.0%
Net Profit
₹23 Cr
▼53.1%
₹49 Cr
▲19.5%
₹41 Cr
▲127.8%
₹18 Cr
▼53.8%
₹39 Cr
▲117.6%
₹-221 Cr
▼76.8%
₹-125 Cr
▼303.2%
₹-31 Cr
▼282.4%
₹17 Cr
▼26.1%
₹23 Cr
EPS (₹)
0.92
▼69.4%
3.01
▼8.0%
3.27
▲64.3%
1.99
▼45.5%
3.65
▲125.0%
-14.58
▼28.3%
-11.36
▼327.1%
-2.66
▼219.3%
2.23
▼8.6%
2.44
Div Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹149 Cr
▲7.2%
₹139 Cr
▲0.0%
₹139 Cr
▲0.0%
₹139 Cr
▲0.0%
₹139 Cr
▲11.2%
₹125 Cr
▲40.4%
₹89 Cr
▲1.1%
₹88 Cr
▲1.1%
₹87 Cr
▲1.2%
₹86 Cr
Reserves
₹1.2K Cr
▲51.1%
₹783 Cr
▲14.1%
₹686 Cr
▼4.9%
₹721 Cr
▼1.4%
₹731 Cr
▲27.8%
₹572 Cr
▲95.2%
₹293 Cr
▼24.7%
₹389 Cr
▼9.1%
₹428 Cr
▲23.3%
₹347 Cr
Borrowings
₹1.7K Cr
▼5.6%
₹1.8K Cr
▲44.2%
₹1.3K Cr
▲41.4%
₹901 Cr
▼1.5%
₹915 Cr
▼6.3%
₹977 Cr
▼27.5%
₹1.3K Cr
▲104.7%
₹658 Cr
▲41.8%
₹464 Cr
▲10.5%
₹420 Cr
Other Liabilities
₹855 Cr
▲9.6%
₹780 Cr
▲29.8%
₹601 Cr
▲9.5%
₹549 Cr
▲26.8%
₹433 Cr
▲21.3%
₹357 Cr
▼31.1%
₹518 Cr
▲0.6%
₹515 Cr
▲11.7%
₹461 Cr
▲23.9%
₹372 Cr
Total Liabilities
₹3.9K Cr
▲10.8%
₹3.5K Cr
▲31.1%
₹2.7K Cr
▲16.9%
₹2.3K Cr
▲4.2%
₹2.2K Cr
▲9.2%
₹2.0K Cr
▼9.6%
₹2.2K Cr
▲36.1%
₹1.6K Cr
▲14.6%
₹1.4K Cr
▲17.6%
₹1.2K Cr
Assets
Fixed Assets
₹2.5K Cr
▲0.8%
₹2.4K Cr
▲38.9%
₹1.8K Cr
▲13.2%
₹1.6K Cr
▲0.4%
₹1.5K Cr
▲11.9%
₹1.4K Cr
▼16.0%
₹1.6K Cr
▲69.7%
₹970 Cr
▲17.1%
₹828 Cr
▲20.9%
₹685 Cr
CWIP
₹19 Cr
▼24.0%
₹25 Cr
▼69.9%
₹83 Cr
▲361.1%
₹18 Cr
▼18.2%
₹22 Cr
▼26.7%
₹30 Cr
▼34.8%
₹46 Cr
▼69.9%
₹153 Cr
▼12.1%
₹174 Cr
▲17.6%
₹148 Cr
Investments
₹14 Cr
▲27.3%
₹11 Cr
▲10.0%
₹10 Cr
▲0.0%
₹10 Cr
▲11.1%
₹9 Cr
▼65.4%
₹26 Cr
▼23.5%
₹34 Cr
▼30.6%
₹49 Cr
▼7.5%
₹53 Cr
▲381.8%
₹11 Cr
Other Assets
₹1.4K Cr
▲34.5%
₹1.1K Cr
▲24.9%
₹850 Cr
▲16.4%
₹730 Cr
▲13.9%
₹641 Cr
▲8.1%
₹593 Cr
▲14.0%
₹520 Cr
▲8.8%
₹478 Cr
▲24.2%
₹385 Cr
▲1.0%
₹381 Cr
Total Assets
₹3.9K Cr
▲10.8%
₹3.5K Cr
▲31.1%
₹2.7K Cr
▲16.9%
₹2.3K Cr
▲4.2%
₹2.2K Cr
▲9.2%
₹2.0K Cr
▼9.6%
₹2.2K Cr
▲36.1%
₹1.6K Cr
▲14.6%
₹1.4K Cr
▲17.6%
₹1.2K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Operating CF
₹347 Cr
▲9.5%
₹317 Cr
▲11.2%
₹285 Cr
▲13.1%
₹252 Cr
▲14.5%
₹220 Cr
▲81.8%
₹121 Cr
▼6.9%
₹130 Cr
▲32.7%
₹98 Cr
▲0.0%
₹98 Cr
▲7.7%
₹91 Cr
Investing CF
₹-177 Cr
▲63.7%
₹-488 Cr
▼115.9%
₹-226 Cr
▼69.9%
₹-133 Cr
▼206.4%
₹125 Cr
▲173.1%
₹-171 Cr
▼69.3%
₹-101 Cr
▲57.6%
₹-238 Cr
▲15.9%
₹-283 Cr
▼34.8%
₹-210 Cr
Financing CF
₹241 Cr
▲673.8%
₹-42 Cr
▲34.4%
₹-64 Cr
▲54.3%
₹-140 Cr
▲9.7%
₹-155 Cr
▼238.4%
₹112 Cr
▲293.1%
₹-58 Cr
▼169.0%
₹84 Cr
▼47.8%
₹161 Cr
▲80.9%
₹89 Cr
Net Cash Flow
₹410 Cr
▲292.5%
₹-213 Cr
▼4160.0%
₹-5 Cr
▲77.3%
₹-22 Cr
▼111.6%
₹190 Cr
▲206.5%
₹62 Cr
▲306.7%
₹-30 Cr
▲46.4%
₹-56 Cr
▼133.3%
₹-24 Cr
▲17.2%
₹-29 Cr
Free Cash Flow
₹59 Cr
▼46.4%
₹110 Cr
▲8.9%
₹101 Cr
▼19.8%
₹126 Cr
▼16.0%
₹150 Cr
▲76.5%
₹85 Cr
▲269.6%
₹23 Cr
▲125.6%
₹-90 Cr
▲43.0%
₹-158 Cr
▼56.4%
₹-101 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Debtor Days
60d
▼9.1%
66d
▲17.9%
56d
▼13.8%
65d
▲14.0%
57d
▼14.9%
67d
▲8.1%
62d
▲5.1%
59d
▲3.5%
57d
▲5.6%
54d
Inventory Days
32d
▼3.0%
33d
▲0.0%
33d
▲0.0%
33d
▲6.5%
31d
▼3.1%
32d
▼8.6%
35d
▼22.2%
45d
▼2.2%
46d
▲15.0%
40d
Days Payable
185d
▼11.9%
210d
▼2.8%
216d
▲0.9%
214d
▲7.5%
199d
▼10.0%
221d
▼5.6%
234d
▼22.8%
303d
▲10.6%
274d
▲0.7%
272d
Cash Conv. Cycle
-93d
▲16.2%
-111d
▲12.6%
-127d
▼9.5%
-116d
▼3.6%
-112d
▲7.4%
-121d
▲11.0%
-136d
▲32.0%
-200d
▼17.0%
-171d
▲3.9%
-178d
Working Capital Days
-61d
▲33.0%
-91d
▼30.0%
-70d
▼75.0%
-40d
▲7.0%
-43d
▼65.4%
-26d
▲74.5%
-102d
▲7.3%
-110d
▼48.6%
-74d
▲33.9%
-112d
ROCE
8.0%
▼11.1%
9.0%
▲0.0%
9.0%
▲12.5%
8.0%
▲60.0%
5.0%
▲600.0%
-1.0%
▼200.0%
1.0%
▼66.7%
3.0%
▼50.0%
6.0%
▼14.3%
7.0%

Source: Screener.in · Lower days = better efficiency

About Healthcare Global Enterprises Limited

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Healthcare · Healthcare Services

Frequently Asked Questions

What is Healthcare Global Enterprises Limited share price today?
Healthcare Global Enterprises Limited (HCG) is currently trading at ₹661.25 on NSE, up 1.15% as of the last market session. Prices update daily after market close on MarketNetra.
Is Healthcare Global Enterprises Limited available in F&O (Futures & Options)?
Yes, Healthcare Global Enterprises Limited (HCG) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Healthcare Global Enterprises Limited 52-week high and low?
Healthcare Global Enterprises Limited's 52-week high is ₹800 and the 52-week low is ₹513. The current price of ₹661.25 is 17.3% below the 52W high.
What is Healthcare Global Enterprises Limited P/E ratio?
Healthcare Global Enterprises Limited's current P/E ratio is 341. This indicates the market is paying ₹341 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Healthcare Global Enterprises Limited options?
Healthcare Global Enterprises Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade HCG options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.